Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogilvy, S.
Right arrow Articles by Adams, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogilvy, S.
Right arrow Articles by Adams, J. M.
Related Collections
Right arrow Plenary Papers
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 94 No. 6 (September 15), 1999: pp. 1855-1863

Promoter Elements of vav Drive Transgene Expression In Vivo Throughout the Hematopoietic Compartment

Sarah Ogilvy, Donald Metcalf, Leonie Gibson, Mary L. Bath, Alan W. Harris, and Jerry M. Adams

From The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.

To develop a method for targeting expression of genes to the full hematopoietic system, we have used transgenic mice to explore the transcriptional regulation of the vav gene, which is expressed throughout this compartment but rarely outside it. Previously, we showed that a cluster of elements surrounding its promoter could drive hematopoietic-specific expression of a bacterial lacZ reporter gene, but the expression was confined to lymphocytes and was sporadically silenced. Those limitations are ascribed here to the prokaryotic reporter gene. With a human CD4 (hCD4) cell surface reporter, the vav promoter elements drove expression efficiently and stably in virtually all nucleated cells of adult hematopoietic tissues but not notably in nonhematopoietic cell types. In multiple lines, hCD4 appeared on most, if not all, B and T lymphocytes, granulocytes, monocytes, megakaryocytes, eosinophils, and nucleated erythroid cells. Moreover, high levels appeared on both lineage-committed progenitors and the more primitive preprogenitors. In the fetus, expression was evident in erythroid cells of the definitive but not the primitive type. These results indicate that a prokaryotic sequence can inactivate a transcription unit and that the vav promoter region constitutes a potent transgenic vector for the entire definitive hematopoietic compartment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. Banerjee, R. Grumont, R. Gugasyan, C. White, A. Strasser, and S. Gerondakis
NF-{kappa}B1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms
Blood, December 15, 2008; 112(13): 5063 - 5073.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Khurana and A. Mukhopadhyay
Hematopoietic Progenitors from Early Murine Fetal Liver Possess Hepatic Differentiation Potential
Am. J. Pathol., December 1, 2008; 173(6): 1818 - 1827.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. He, H. Hu, R. Braren, S.-Y. Fong, A. Trumpp, T. R. Carlson, and R. A. Wang
c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo
Development, July 15, 2008; 135(14): 2467 - 2477.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. J. Salmond, L. McNeill, N. Holmes, and D. R. Alexander
CD4+ T cell hyper-responsiveness in CD45 transgenic mice is independent of isoform
Int. Immunol., July 1, 2008; 20(7): 819 - 827.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
C. Slape, Y. W. Lin, H. Hartung, Z. Zhang, L. Wolff, and P. D. Aplan
NUP98-HOX Translocations Lead to Myelodysplastic Syndrome in Mice and Men
J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 64 - 68.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Tiedt, H. Hao-Shen, M. A. Sobas, R. Looser, S. Dirnhofer, J. Schwaller, and R. C. Skoda
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Blood, April 15, 2008; 111(8): 3931 - 3940.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Ogilvy, R. Ferreira, S. G. Piltz, J. M. Bowen, B. Gottgens, and A. R. Green
The SCL +40 Enhancer Targets the Midbrain Together with Primitive and Definitive Hematopoiesis and Is Regulated by SCL and GATA Proteins
Mol. Cell. Biol., October 15, 2007; 27(20): 7206 - 7219.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Caudell, Z. Zhang, Y. J. Chung, and P. D. Aplan
Expression of a CALM-AF10 Fusion Gene Leads to Hoxa Cluster Overexpression and Acute Leukemia in Transgenic Mice
Cancer Res., September 1, 2007; 67(17): 8022 - 8031.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. P. Smith, M. L. Bath, D. Metcalf, A. W. Harris, and S. Cory
MYC levels govern hematopoietic tumor type and latency in transgenic mice
Blood, July 15, 2006; 108(2): 653 - 661.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Wiesner, J. M. Jones, D. E. Hasz, and D. A. Largaespada
Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse
Blood, August 1, 2005; 106(3): 1054 - 1062.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-W. Lin, C. Slape, Z. Zhang, and P. D. Aplan
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia
Blood, July 1, 2005; 106(1): 287 - 295.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Stadtfeld and T. Graf
Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing
Development, January 1, 2005; 132(1): 203 - 213.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Coultas, P. Bouillet, E. G. Stanley, T. C. Brodnicki, J. M. Adams, and A. Strasser
Proapoptotic BH3-Only Bcl-2 Family Member Bik/Blk/Nbk Is Expressed in Hemopoietic and Endothelial Cells but Is Redundant for Their Programmed Death
Mol. Cell. Biol., February 15, 2004; 24(4): 1570 - 1581.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Ogilvy, C. Louis-Dit-Sully, J. Cooper, R. L. Cassady, D. R. Alexander, and N. Holmes
Either of the CD45RB and CD45RO Isoforms Are Effective in Restoring T Cell, But Not B Cell, Development and Function in CD45-Null Mice
J. Immunol., August 15, 2003; 171(4): 1792 - 1800.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. S. Radomska, D. A. Gonzalez, Y. Okuno, H. Iwasaki, A. Nagy, K. Akashi, D. G. Tenen, and C. S. Huettner
Transgenic targeting with regulatory elements of the human CD34 gene
Blood, December 15, 2002; 100(13): 4410 - 4419.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Ogilvy, D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams
Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival
PNAS, December 21, 1999; 96(26): 14943 - 14948.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020